A detailed history of Nilsine Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nilsine Partners, LLC holds 3,723 shares of EW stock, worth $321,294. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,723
Previous 2,742 35.78%
Holding current value
$321,294
Previous $214 Million 35.01%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 06, 2025

BUY
$73.75 - $81.83 $72,348 - $80,275
981 Added 35.78%
3,723 $290 Million
Q2 2025

Jul 31, 2025

BUY
$67.07 - $78.22 $183,905 - $214,479
2,742 New
2,742 $214 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.